Gallbladder squamous cell carcinoma in the setting of low-dose methotrexate use.
Azad
A
A
Chionh
F
F
Jayarajan
J
J
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000556:secondary / Q000628:therapy*; D017081:Cholecystectomy, Laparoscopic; D002945:Cisplatin / Q000008:administration & dosage; D003879:Dermatologic Agents / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D017809:Fatal Outcome; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005706:Gallbladder Neoplasms / Q000473:pathology / Q000628:therapy*; D042882:Gallstones / Q000601:surgery; D006801:Humans; D033162:Incidental Findings; D008113:Liver Neoplasms / Q000556:secondary; D008727:Methotrexate / Q000008:administration & dosage*; D009366:Neoplasm Seeding; D010534:Peritoneal Neoplasms / Q000556:secondary; D011565:Psoriasis / Q000188:drug therapy*
D003879:Dermatologic Agents; D002945:Cisplatin; D005472:Fluorouracil; D008727:Methotrexate